RE: Insane Spread31 Jul 2024 05:39
Anyway, stepping back to trans points regarding the company rather than the gripes.
- no route to market.
Correct there is currently no planned route to market for any of NFX products. The company has explicitly stated this is not their aim, they are just a drug development company and have no plans to take any product to market.
- no income only expenditure
To be expected from a development company, they will only get income through signing an outlicensing deal.
-no plan made public
The plan is to outlicense the patents, this doesn’t have a prescribed timeline. It’s up to the parties involved to worked it through.
NFX is a binary bet, you either think they will sign an outlicensing deal that is worth more than the current company valuation of 1.5m or you don’t.
Forget income, forget routes to market, forget timelines… it’s either going to be a deal or zero